Scientists test new sickle cell pill formulas in healthy people
NCT ID NCT06291285
Summary
This early-stage study tested two different pill versions of an experimental drug combination for sickle cell disease. The goal was to see how the body absorbs a tablet versus a capsule. The study involved 44 healthy volunteers who took both versions in a random order to compare them.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON-Salt Lake City
Salt Lake City, Utah, 84124, United States
-
Profil Institut für Stoffwechselforschung GmbH
Neuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.